Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%) Natco Pharma informs about analyst meet
Date: 27-02-2025Natco Pharma has informed that it enclosed the disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the officials of the Company will be participating in the investor meeting.
The above information is a part of company’s filings submitted to BSE.